"The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternat"...
No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.
Last reviewed on RxList: 1/15/2016
This monograph has been modified to include the generic and brand name in many instances.
Additional Ofirmev Information
Report Problems to the Food and Drug Administration
Chronic Pain/Back Pain
Find tips and advances in treatment.